Under construction – not a live service
Sign in

NCT06011577TerminatedPhase 3

Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD

A Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as an Adjunctive Treatment for Major Depressive Disorder (RELIGHT)

Source: ClinicalTrials.gov · Last updated 10 Jul 2026

Brief summary (registry, in English)

A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).

Status (registry)
Terminated
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
27 (actual)
First submitted
21 Aug 2023
Start date
17 Aug 2023
Primary completion date
19 Dec 2024
Lead sponsor
Levomecor Inc.
Diseases
Depression
NCT number
NCT06011577

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Psychiatric hospitalization during the current major depressive episode.
  • History or presence of clinically significant health conditions which in the opinion of the Investigator would negatively impact the safety of the participant.

Other

  • Participants who, in the Investigator's judgment, are at significant risk for suicide.
  • Pregnant or planning to become pregnant.

Who the study is looking for

  • Body mass index (BMI) between 18.0 and 35.0 kg/m2.
  • Diagnosed with Major Depressive Disorder (MDD) based on Structured Clinical Interview for DSM-5 (SCID-5) for MDD.
  • Inadequate response to 1 to 3 adequate antidepressant treatments in the current MDE.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (35)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
-AnaheimUnited StatesUnknown status
-AustinUnited StatesUnknown status
-BaltimoreUnited StatesUnknown status
-BellaireUnited StatesUnknown status
-BrandonUnited StatesUnknown status
-BrooklynUnited StatesUnknown status
-CedarhurstUnited StatesUnknown status
-CharlottesvilleUnited StatesUnknown status
-ClintonUnited StatesUnknown status
-DothanUnited StatesUnknown status
-DraperUnited StatesUnknown status
-FarmingtonUnited StatesUnknown status
-FranklinUnited StatesUnknown status
-FriendswoodUnited StatesUnknown status
-HialeahUnited StatesUnknown status
-HomewoodUnited StatesUnknown status
-HoustonUnited StatesUnknown status
-JacksonvilleUnited StatesUnknown status
-LafayetteUnited StatesUnknown status
-MankatoUnited StatesUnknown status
-MemphisUnited StatesUnknown status
-MiamiUnited StatesUnknown status
-Newport BeachUnited StatesUnknown status
-New YorkUnited StatesUnknown status
-OkeechobeeUnited StatesUnknown status
-OrangeUnited StatesUnknown status
-PhiladelphiaUnited StatesUnknown status
-RedlandsUnited StatesUnknown status
-RutlandUnited StatesUnknown status
-SeattleUnited StatesUnknown status
-Sherman OaksUnited StatesUnknown status
-SpringfieldUnited StatesUnknown status
-TampaUnited StatesUnknown status
-Toms RiverUnited StatesUnknown status
-Wichita FallsUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.